Skip to main content
BIOTRON LIMITED logo

BIOTRON LIMITED — Investor Relations & Filings

Ticker · BIT ISIN · AU000000BIT4 ASX Professional, scientific and technical activities
Open in API
Filings indexed 765 across all filing types
Latest filing 2019-02-19 Interim / Quarterly Rep…
Country AU Australia
Listing ASX BIT

About BIOTRON LIMITED

https://www.biotron.com.au

Biotron Limited is a clinical-stage company focused on the development of novel small molecule antiviral therapeutics. The company utilizes its proprietary ViroPore technology platform to design and develop drugs that target viroporins—a class of proteins found in a wide range of viruses that play critical roles in viral replication and the evasion of host immune responses. Biotron's primary clinical program centers on BIT225, a first-in-class inhibitor targeting the HIV-1 Vpu protein and the Hepatitis C virus p7 protein. The company aims to address unmet medical needs by developing treatments that can potentially eradicate viral reservoirs and improve patient outcomes. In addition to HIV and HCV, Biotron is exploring the application of its antiviral platform against other significant viral pathogens, including SARS-CoV-2, leveraging its expertise in ion channel-targeting chemistry to disrupt the viral life cycle.

Recent filings

Filing Released Lang Actions
Half Yearly Report and Accounts 20 pages 1.8MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM FINANCIAL REPORT FOR THE HALF-YEAR ENDED 31 DECEMBER 2018' and includes detailed financial statements such as the Condensed Interim Statement of Profit or Loss, Statement of Financial Position, Cash Flows, and Notes to the Financial Statements. It also contains a Directors' Report and an Independent Auditor’s Review Report. The document references the half-year period ending 31 December 2018, which is a period shorter than a full fiscal year. The content includes substantive financial data and analysis, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2019-02-19 English
Appendix 3B 13 pages 1.0MB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a New Issue Announcement and Application for Quotation of Additional Securities submitted to the ASX (Australian Securities Exchange). It details the issuance of fully paid ordinary shares, the number of securities issued, issue price, and compliance with ASX Listing Rules. The document includes sections on quotation agreements and calculation of placement capacity under ASX rules. It is not a financial report, earnings release, or management discussion, but a regulatory announcement about new share issuance and quotation application. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed information about the new issue, not just a brief announcement or a report publication notice.
2019-02-11 English
Appendix 4C - quarterly 5 pages 705.2KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B' and contains detailed consolidated cash flow statements for the current quarter and year to date, including operating, investing, and financing activities. It also includes payments to directors and related entities, financing facilities, estimated cash outflows for the next quarter, and a compliance statement signed by the company secretary. The document is approximately 9,134 characters long, which is substantial and contains actual financial data and analysis for a quarterly period. The presence of detailed financial statements and cash flow data for a quarter aligns with the definition of an Interim / Quarterly Report (IR). It is not merely an announcement or certification but a full quarterly financial report. Therefore, the appropriate classification is IR (Interim / Quarterly Report).
2019-01-17 English
Appendix 3B 13 pages 1.0MB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a New Issue Announcement and Application for Quotation of Additional Securities submitted to the ASX (Australian Securities Exchange). It details the issuance of new fully paid ordinary shares, the number of securities issued, issue price, and compliance with ASX Listing Rules. The document includes sections on quotation agreements and calculation of placement capacity under ASX rules. This type of filing is specifically related to capital raising and changes in the company's capital structure, not a financial report or management discussion. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and content confirm it is the actual announcement, not just a brief notice or a report publication announcement.
2019-01-16 English
Appendix 3B 13 pages 1.0MB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a New Issue Announcement and Application for Quotation of Additional Securities submitted to the ASX (Australian Securities Exchange). It details the issuance of 200,000 fully paid ordinary shares, the terms of the securities, issue price, purpose, and compliance with ASX listing rules. The document is a regulatory filing specifically related to capital raising and securities issuance, not a financial report or earnings release. It is not a report publication announcement since it contains substantive information about the new issue. Therefore, the document fits the category of Capital/Financing Update (CAP).
2019-01-06 English
Appendix 3B 13 pages 1.0MB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a New Issue Announcement and Application for Quotation of Additional Securities submitted to the ASX (Australian Securities Exchange). It details the issuance of new fully paid ordinary shares, the number of securities issued, issue price, and compliance with ASX Listing Rules. The document includes sections on quotation agreements and calculation of placement capacity under ASX rules. It is not a financial report, earnings release, or management discussion, but a regulatory announcement related to capital raising and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed information about the securities issuance, confirming it is not merely an announcement of a report but the actual filing of the new issue details.
2018-12-13 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.